AndraUrsuta.com – In the randomized, controlled Sidus Shoulder Replacement study, 83 percent of patients met the success criteria. Patients had a clinical success rate of 87%, compared with 72% to 94% for historical control. Patients in this study were enrolled at 11 clinical sites across the U.S. and Canada. Before data collection, all participants signed informed consent forms. The researchers also made sure that patients met inclusion and exclusion criteria. Sidus humeral head and anchor and Anatomical Shoulder polyethylene glenoid component were provided by Zimmer Biomet.
The wide osteotomy slot also makes separation of the humerus simple
The Sidus Shoulder Replacement technique is a simple, single-layer tray that weighs less than 10 pounds. The Top of Anchor includes four large windows that allow the surgeon to see the humerus during insertion. The wide osteotome slots also make disassociation from the humerus simple. The entire procedure takes about three hours. Patients typically spend around one week in recovery. The Sidus Shoulder Replacement procedure may take one to two hours.
The first step in the Sidus Shoulder Replacement procedure is removing the degenerated humeral head. The implanted prosthesis is then inserted into the joint and secured with a thumb screw. This step is critical because if the implant is not placed correctly, the patient may have a hard time moving it back to the correct position. The surgeon must then align the supraspinatus to restore the humerus back to its native anatomy.
This new technology will help doctors to restore the anatomy of the shoulder
The Sidus Shoulder Replacement system was designed to restore anatomy while preserving bone stock. It will improve the range of motion and pain of the patient after surgery. Zimmer Biomet hopes to launch the stem-free Sidus Shoulder Replacement in the first quarter of 2017. This new technology will help physicians restore the anatomy of the shoulder and help patients move back to their daily activities. These positive results should help the company continue its leadership role in shoulder replacement solutions.
At 2 years of follow-up, patients with the Sidus stem-free shoulder showed good clinical results. During this time, ASES scores, range of motion, and patient satisfaction all improved significantly. Interestingly, the success rate of Sidus shoulder replacement was 98%. Moreover, radiographic results showed that 93 percent of the implants remained viable at two years, while no evidence of osteolysis or migration was observed. It is important to note that this new shoulder replacement technique is still in its early stages, so patients should be cautious when making a decision.
This rehabilitation program is the same for all the subjects listed
The operative procedure was performed without a steroid. The humeral head component was wrongly removed and hit the glenoid bone, resulting in shifting of the implant. The surgical team substituted a standard-length stemmed humeral component. This shifted the Sidus implant. Afterward, the implants remained stable. Patients were also encouraged to follow a standard rehabilitation program. This rehabilitation program is similar for all enrolled subjects.
The new implant will allow surgeons to avoid bone resection
The Sidus shoulder replacement surgery is performed on patients with significant glenohumeral arthritis, proximal humerus deformity, or severe osteoporosis. The new implant will allow surgeons to avoid bone resection. A stemless device can save surgeons time and blood. Furthermore, it is easy to revise. Therefore, patients can undergo this procedure in a single day.
Patients in the IDE trial underwent Sidus shoulder arthroplasty for symptomatic right glenohumeral joint osteoarthritis. Moreover, they had a 94.5% compliance rate during follow-up, with no serious complications. The results of the randomized trial are summarized in Table 1.
Patients who cannot undergo Sidus Shoulder Replacement must have major joint trauma, avascular necrosis, infection, or chronic dislocation. In addition, patients with vascular insufficiency cannot undergo the surgery. Additionally, patients on systemic steroids or radiation cannot undergo the procedure. Insufficient bone stock in the glenoid also affects the results of surgery. This can prevent the patient from fully recovering. Therefore, patients with these medical conditions should be evaluated by their doctors.